Minnesota Hospital to Pay U.S. to Resolve Allegations of False Claims Involving Unnecessary Admissions

Wheaton Community Hospital, the City of Wheaton (MN), and Dr. Stanley Gallagher have agreed to pay the United States $846,461.00 to settle allegations that their hospital admission practices violated the False Claims Act.  In particular, the suit against Wheaton Community Hospital, the City, and Dr. Gallagher alleged that they admitted some patients and kept others admitted to acute care when doing so was not medically necessary.

Michigan Health Care Provider to Pay United States $669,413 to Settle False Claims Allegations

Genesys Health System, a Michigan-based health care service provider, has agreed to pay the United States $669,413.00 to settle allegations that it submitted false claims to Medicare. Specifically, a whistleblower’s qui tam suit alleged that from 2001 through 2007, Genesys repeatedly billed Medicare for higher levels of service than were actually provided to the company’s cardiology patients.

Four companies pay $39 million to settle California whistleblower case involving water supply system parts

A state whistleblower claim brought under California’s False Claims Act settled for $39 million last month, bringing to almost $60 million the total recovery that California water districts and municipalities, including the cities of San Francisco and Los Angeles, have recovered because of excessive lead levels in water valves and fittings manufactured by James Jones Company LLC.

Case Studies Show Fraud and Abuse Allowed Ineligible Firms to Obtain Millions of Dollars in Contracts

The U.S. Government Accountability Office (GAO) released a report on November 19 finding that contractors falsely claiming to be run by disabled military veterans have defrauded the government of at least $100 million since 2003.  Congress established goals for the distribution of a certain portion of federal contracts to small businesses that are owned and operated by vets injured in the course of active duty.

AtriCure Pays $3.8M to Settle With U.S.

The manufacturer of devices for treatment of atrial fibrillation (irregular heartbeats) tentatively settled with the US Department of Justice allegations of false claims for $3.8 million.  The DOJ claimed that the manufacturer, AtriCure, marketed its devices beyond the scope of its FDA clearance and by instructing hospitals to use incorrect Medicare billing codes.

Contact one of our

Experienced Attorneys

If you are aware of any person, corporation or entity that you think may be violating the Federal False Claims Act or a State False Claims Act, contact us today.

CONTACT US